ENTITY

Yantai Dongcheng Pharmaceuticl Gp (002675 CH)

13
Analysis
Health CareChina
Yantai Dongcheng Pharmaceutical Co Ltd is an enterprise group that combines pharmaceutical R&D, production, marketing, and capital operations across the fields of biochemical API, chemical synthetic drugs, and modern Chinese medicine.
more
Refresh
18 Aug 2016 18:43

Small Improvement in China Air Quality

Air quality in China appears to have improved slightly in recent months. However, it is still well above World Health Organisation recommended...

Logo
Bixmoor
220 Views
Share
04 Aug 2016 16:39

Critique of Genome Scientific Work

China’s state media reported this week that Han Chunyu’s scientific results on genome editing which were published in Nature Biotechnology in May...

Logo
Bixmoor
223 Views
Share
04 Aug 2016 16:05

China's Disconnect on Illegal Drugs

Senior Chinese officials regularly make all the appropriate noises about the evils of illicit drug use in China, but they seem unable to do...

Logo
Bixmoor
607 Views
Share
26 Feb 2016 05:38

Coming to the HKEX Soon....................

Bloomberg has published a story (that others have cited) that WuXi Pharmatech has picked bankers for an HK listing of its biologics manufacturing...

Share
18 Feb 2016 23:01

Time to Go Shopping for Healthcare

The decline in equity markets has created opportunities to buy a variety of healthcare stocks at attractive valuations. Insider purchases have...

Share
x